| Title |
Background Rates of Adverse Pregnancy Outcomes for Assessing the Safety of Maternal Vaccine Trials in Sub-Saharan Africa
|
|---|---|
| Published in |
PLOS ONE, October 2012
|
| DOI | 10.1371/journal.pone.0046638 |
| Pubmed ID | |
| Authors |
Lauren A. V. Orenstein, Evan W. Orenstein, Ibrahima Teguete, Mamoudou Kodio, Milagritos Tapia, Samba O. Sow, Myron M. Levine |
| Abstract |
Maternal immunization has gained traction as a strategy to diminish maternal and young infant mortality attributable to infectious diseases. Background rates of adverse pregnancy outcomes are crucial to interpret results of clinical trials in Sub-Saharan Africa. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| New Zealand | 1 | 25% |
| Australia | 1 | 25% |
| United States | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ethiopia | 1 | 1% |
| Canada | 1 | 1% |
| Switzerland | 1 | 1% |
| Unknown | 96 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 18 | 18% |
| Researcher | 12 | 12% |
| Student > Ph. D. Student | 12 | 12% |
| Other | 7 | 7% |
| Student > Postgraduate | 6 | 6% |
| Other | 18 | 18% |
| Unknown | 26 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 39% |
| Nursing and Health Professions | 7 | 7% |
| Psychology | 4 | 4% |
| Economics, Econometrics and Finance | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Other | 15 | 15% |
| Unknown | 28 | 28% |